Altrinsic Global Advisors LLC Atara Biotherapeutics, Inc. Transaction History

Altrinsic Global Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$8.44 - $16.89 $844,000 - $1.69 Million	-100,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$11.99 - $17.9 $119,900 - $179,000	10,000 Added 11.11%	100,000 $1.79 Million
Q2 2021 Aug 13, 2021	BUY	$12.89 - $16.58 $128,900 - $165,799	10,000 Added 12.5%	90,000 $1.4 Million
Q3 2020 Nov 16, 2020	BUY	$11.92 - $15.87 $357,600 - $476,100	30,000 Added 60.0%	80,000 $1.04 Million
Q2 2020 Aug 14, 2020	BUY	$7.53 - $14.93 $376,500 - $746,500	50,000 New	50,000 $729,000

3.07M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $763M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Altrinsic Global Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Altrinsic Global Advisors LLC with notifications on news.